Description
Key facts
Detection method:Colorimetric,
Sample types:Urine, Cell culture media, Heparin Plasma, Citrate plasma, Cell culture supernatant, Serum, EDTA Plasma,
Reacts with:Human,
Assay type:Sandwich (quantitative),
Sensitivity:= 10.81 pg/mL,
Range:18.75 - 1200 pg/mL,
Assay time:1h 30m,
Assay Platform:Pre-coated microplate (12 x 8 well strips)
Product details:
Human BCMA ELISA Kit ab263875 is a rapid single-wash 90-min Sandwich ELISA to measure Human BCMA in cell culture media, cell culture supernatant, citrate plasma, EDTA plasma, heparin plasma, serum, urine. This SimpleStep sensitivity is 10.81 pg/mL.
How the assay works
Human BCMA SimpleStep ELISA
employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA
plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA
protocol summary in the image section for further details.
Assay Specificity
Our SimpleStep ELISA
kits use recombinant monoclonal antibodies rigorously validated to ensure the highest level of consistency and reproducibility, improved sensitivity and specificity and ease of scalability and security of supply.
Please refer to our protocol booklet for more details.
Human BCMA ELISA Kit ab263875 protocol summary
1. Mix: add samples/standards to the wells together with the capture and detector antibody cocktail. Incubate 1 hr at room temperature
2. Wash
3. Add TMB development solution - incubate for 10 min
4. Add Stop solution
5. Read the results on a plate reader at 450 nm
Design your own immunoassay
We offer the antibody pair used in this kit in a BSA and Azide-free format, ready for conjugation:
- Anti-BCMA antibody [EPR22457-30] - BSA and Azide free (Capture)
ab267460
- Anti-BCMA antibody [EPR22457-28] - BSA and Azide free (Detector)
ab267460
Tumor necrosis factor receptor superfamily member 17 (BCMA) is a receptor involved in B cell survival. BCMA activates the NF-kappa-B and JNK pathways. Aberrant expression of BCMA is observed on malignant B cells, including during multiple myeloma, Hodgkin's lymphoma, and Waldenstrom's macroglobulinemia.
Properties and Storage Information:
Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-+4°C
